Institute of Pathology

Natural medicines for radioprotection and radiosensitization: a bibliometric analysis of mechanisms and trends (2001–2025) (2026) Di Y, Song J, Wang Y, Meng L, Li J Journal article, Review article Quo Vadis colorectal intramucosal adenocarcinoma? (2026) Deshpande V, Bateman AC, Bal M, Chetty R, Loughrey MB, Shia J, Vieth M, et al. Journal article The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review (2026) Fiegl A, Mink J, Junker K, Hartmann A, Eckstein M Journal article, Review article Expression of the immune checkpoint CD137/CD137L in oral squamous cell carcinoma (OSCC) and association with histopathological parameters (2026) Glajzer J, Ries J, Trumet L, Matek C, Kesting MR, Weber M Journal article Update on the regression grading of non-small cell lung cancer Update zur Regressionsgraduierung nichtkleinzelliger Lungenkarzinome (2026) Elsner F, Löwer-Kiem LM, Fuchs F, Berezowska S, Steinestel K Journal article EP300::VGLL3 fused rhabdomyoblastic tumor revisited: Is the label “rhabdomyosarcoma” justified? (2026) Agaimy A, Thway K, Fisher C Journal article Nectin-4 in bladder cancer: biology and predictive biomarker potential. (2026) Roessler N, Miszczyk M, Berger W, Englinger B, Eckstein M, Shariat SF Journal article, Review article Artificial intelligence in surgical disciplines: Clinical application, advantages, and potential—a Delphi expert consensus Künstliche Intelligenz in chirurgischen Disziplinen: Einsatz, Nutzen und Potenzial – ein Delphi-Expertenkonsensus (2026) Duwe G, Moench K, Kauth V, Angeloni M, Eckhoff J, Görtz M, Hoefert S, et al. Journal article Localised Urothelial Carcinoma of the Upper Urinary Tract: Histopathology, Molecular Genetics, and Clinical Features Urothelkarzinom des oberen Harntrakts – lokalisiert: Histopathologie, Molekulargenetik und klinische Besonderheiten (2026) Bahlinger V, Maas M, Bolenz C, Hartmann A Journal article, Review article From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma Von ungezielt zu Präzisionsonkologie: Prädiktive Biomarker und Target-Therapien beim fortgeschrittenen Urothelkarzinom (2026) Niegisch G, Zschäbitz S, Eckstein M, Klümper N Journal article, Review article